Pluri Inc. Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives
Pluri Inc. (PLUR) reported Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives of $346.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives · last filed 2026-09-10
- Pluri Inc. gain (loss) on foreign currency fair value hedge derivatives for the quarter ending 2026-06-30 was -$2.00K, a 100.99% decline year-over-year.
- Pluri Inc. gain (loss) on foreign currency fair value hedge derivatives for the quarter ending 2026-03-31 was $6.00K.
- Pluri Inc. gain (loss) on foreign currency fair value hedge derivatives for the quarter ending 2025-12-31 was $53.00K, a 0.00% change year-over-year.
- Pluri Inc. gain (loss) on foreign currency fair value hedge derivatives for the quarter ending 2025-09-30 was $289.00K, a 478.00% increase year-over-year.
- Pluri Inc. gain (loss) on foreign currency fair value hedge derivatives for fiscal 2026 was $346.00K, a 37.85% increase from fiscal 2025.
- Pluri Inc. gain (loss) on foreign currency fair value hedge derivatives for fiscal 2025 was $251.00K, a 69.59% increase from fiscal 2024.
- Pluri Inc. gain (loss) on foreign currency fair value hedge derivatives for fiscal 2024 was $148.00K.
- Pluri Inc. gain (loss) on foreign currency fair value hedge derivatives for fiscal 2023 was -$157.00K.
| Period end | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 3 month | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 6 month | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 9 month | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 12 month | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $4.00K derived: sum of 2 quarters · filed 2026-09-10 | $57.00K derived: sum of 3 quarters · filed 2026-09-10 | $346.00K 10-K · filed 2026-09-10 | |
| 2026-03-31 | $6.00K 10-Q · filed 2026-05-14 | $59.00K derived: sum of 2 quarters · filed 2026-05-14 | $348.00K 10-Q · filed 2026-05-14 | $551.00K derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-12-31 | $53.00K 10-Q · filed 2026-02-12 | $342.00K 10-Q · filed 2026-02-12 | $545.00K derived: sum of 3 quarters · filed 2026-09-10 | $490.00K derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-09-30 | $289.00K 10-Q · filed 2025-11-12 | $492.00K derived: sum of 2 quarters · filed 2026-09-10 | $437.00K derived: sum of 3 quarters · filed 2026-09-10 | $490.00K derived: sum of 4 quarters · filed 2026-09-10 | |
| 2025-06-30 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $148.00K derived: sum of 2 quarters · filed 2026-09-10 | $201.00K derived: sum of 3 quarters · filed 2026-09-10 | $251.00K 10-K · filed 2026-09-10 | |
| 2025-03-31 | -$55.00K 10-Q · filed 2026-05-14 | -$2.00K derived: sum of 2 quarters · filed 2026-05-14 | $48.00K 10-Q · filed 2026-05-14 | $64.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $53.00K 10-Q · filed 2026-02-12 | $103.00K 10-Q · filed 2026-02-12 | $119.00K derived: sum of 3 quarters · filed 2026-02-12 | $47.00K derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-09-30 | $50.00K 10-Q · filed 2025-11-12 | $66.00K derived: sum of 2 quarters · filed 2025-11-12 | -$6.00K derived: sum of 3 quarters · filed 2025-11-12 | $201.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | -$56.00K derived: sum of 2 quarters · filed 2025-09-17 | $151.00K derived: sum of 3 quarters · filed 2025-09-17 | $148.00K 10-K · filed 2025-09-17 | |
| 2024-03-31 | -$72.00K 10-Q · filed 2025-05-13 | $135.00K derived: sum of 2 quarters · filed 2025-05-13 | $132.00K 10-Q · filed 2025-05-13 | ||
| 2023-12-31 | $207.00K 10-Q · filed 2025-02-11 | $204.00K 10-Q · filed 2025-02-11 | |||
| 2023-09-30 | -$3.00K 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | -$157.00K 10-K · filed 2024-09-18 | ||||
| 2022-06-30 | -$372.00K 10-K · filed 2023-09-12 | ||||
| 2021-06-30 | $35.00K 10-K · filed 2022-09-21 | ||||
| 2020-06-30 | $13.00K 10-K · filed 2021-09-13 | -$13.00K 10-K · filed 2020-09-10 | |||
| 2019-06-30 | $105.00K 10-K · filed 2020-09-10 | ||||
| 2018-06-30 | $264.00K 10-K · filed 2020-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |